Skip To Main Content
Shannon Firth on Muck Rack

Shannon Firth

Verified
As seen in: MedPage Today, MSN, ABC News, U.S. News and World Report, The Week Magazine (US), Veterans Today, KPBS-TV (San Diego, CA), Narratively, Center for Health Journalism, HealthLeaders, EMS1 and
Washington correspondent for @MedPageToday @cunyjschool pride. Tweets, RTs not endorsements.

Get in touch with Shannon

Contact Shannon, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

DEA schedules widely available opioid compounds as controlled substances

|
By Shannon Firth Verified
| MSN Verified
The Drug Enforcement Administration (DEA) announced that it issued a temporary order to schedule three opioid compounds as controlled substances. "The DEA bases this action on a finding that placing mitragynine pseudoindoxyl, MGM-15, and MGM-16 in Schedule I is necessary to avoid an imminent hazard to public safety," the rule, published in the Federal Register , noted. From February 2025 to May 2026, mitragynine pseudoindoxyl was linked to at least 56 overdose cases, of which 48 were fatal.
Open in Who Shared Issue with article?

For opioid overdose survivors, one treatment may reduce risk of death over another

|
By Shannon Firth Verified
| MSN Verified
For opioid overdose survivors, starting methadone was associated with a reduced risk of death during the subsequent year compared with starting buprenorphine-naloxone, a retrospective cohort study from Canada suggested. Using a target trial emulation among over 5,800 individuals with past-year opioid overdose, 5.6% of those who started methadone died within 1 year compared with 7.1% of those who started buprenorphine-naloxone (HR 0.78, 95% CI 0.63-0.95, P =0.01), reported Robert A.
Open in Who Shared Issue with article?

Trump administration takes second swing at hefty fees for visa applicants

|
By Shannon Firth Verified
| MSN Verified
The Trump administration has doubled down on its efforts to discourage employers from seeking skilled foreign workers, including physicians, through the H-1B visa program, publishing a new draft rule on Tuesday. The proposed rule would require a $103,265 fee for certain visa applications, typically paid for by employers. Revenue from the charges would be funneled to the legal immigration system, including federal immigration courts and U.S. Immigration and Customs Enforcement.
Open in Who Shared Issue with article?
See all 170 licensed articles (1,028 Total)